// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

Adjuvant chemotherapy following pancreaticoduodenectomy for pancreatic ductal adenocarcinoma – inter-hospital variability in uptake

A. Sultana - International Hepato-Pancreato-Biliary Association (IHPBA) , 2018

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Pancreas ductal adenocarcinoma

N/A

Adjuvant chemotherapy following pancreaticoduodenectomy for pancreatic ductal adenocarcinoma – factors affecting receipt and completion of chemotherapy

A. Sultana - International Hepato-Pancreato-Biliary Association (IHPBA) , 2018

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Pancreas ductal adenocarcinoma

N/A

A genome-wide screen for inherited genetic variants that affect survival and therapy of resectable pancreatic ductal adenocarcinoma

C. Dimitrakopoulos - International Hepato-Pancreato-Biliary Association (IHPBA) , 2018

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Pancreas ductal adenocarcinoma

N/A

18FDG PET/CT improves staging of small ≤2 cm pancreatic tumours

E. Mohamed - International Hepato-Pancreato-Biliary Association (IHPBA) , 2018

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Pancreatic cancer

N/A

External versus internal pancreatic duct stenting in duct-to-mucosa pancreaicojejunostomy after pancreaticoduodenectomy: a prospective randomized study

M. Sharshar - International Hepato-Pancreato-Biliary Association (IHPBA) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Contemporary outcomes after pancreatoduodenectomy in a complete national cohort: short-term morbidity and mortality within a universal health care system

L.S. Nymo - International Hepato-Pancreato-Biliary Association (IHPBA) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

The impact of age on treatment for pancreatic ductal adenocarcinoma (PDAC) with curative intent: is age a barrier?

A.K. Malik - International Hepato-Pancreato-Biliary Association (IHPBA) , 2018

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Pancreas ductal adenocarcinoma

N/A

Early predictors of clinically relevant post-operative pancreatic fistula after pancreaticoduodenectomy

A. Pinter Carvalheiro da Silva Boteon - International Hepato-Pancreato-Biliary Association (IHPBA) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Diagnostic accuracy of computed tomographic (CT) angiography for detection of post-pancreatectomy haemorrhage

M. Pease - International Hepato-Pancreato-Biliary Association (IHPBA) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Long term oncological outcomes of resection for duodenal adenocarcinoma

E. Kontis - International Hepato-Pancreato-Biliary Association (IHPBA) , 2018

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Duodenal cancer

N/A

Incisional hernia rate in midline vs transverse incision for major pancreatic surgery

G. Lane - International Hepato-Pancreato-Biliary Association (IHPBA) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

A novel technique for pancreatic stump closure following distal pancreatectomy – The CLASP technique

M. Papoulas - International Hepato-Pancreato-Biliary Association (IHPBA) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Laparoscopic "antegrade standard pancreatosplenectomy” – A new approach following oncological principles

M. Papoulas - International Hepato-Pancreato-Biliary Association (IHPBA) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Lymph node ratio predicts recurrence following resections of non-functional pancreatic neuro-endocrine tumours (NF-PNET): a rational approach to postoperative surveillance

M. Feretis - International Hepato-Pancreato-Biliary Association (IHPBA) , 2018

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Neuroendocrine tumor

N/A

Comparison of drain fluid lipase with drain fluid amylase in the context of post-operative pancreatic fistula

M. Roy - International Hepato-Pancreato-Biliary Association (IHPBA) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

lipase

Pancreatic head resection for sphincter of oddi dysfunction

E.J. Ban - International Hepato-Pancreato-Biliary Association (IHPBA) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Is the routine histopathological analysis of all gallbladders justified?

A. Fanshawe - International Hepato-Pancreato-Biliary Association (IHPBA) , 2018

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Mucosa-associated lymphoid tissue lymphoma

N/A

Early cholecystectomy can be performed in a safe and timely manner at a district general hospital in accordance with NICE guidelines

J. Yee - International Hepato-Pancreato-Biliary Association (IHPBA) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Remnant cholecystectomy: is it worthwhile doing?

S. Aroori - International Hepato-Pancreato-Biliary Association (IHPBA) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Informed consent in elective and emergency laparoscopic cholecystectomy: is patients' knowledge a complication?

E. Iaculli - International Hepato-Pancreato-Biliary Association (IHPBA) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Copyright © 2026. QuantiNova All rights reserved